Stereotactic radiosurgery for the treatment of brain metastases.

BACKGROUND The objective of this systematic review was to summarise the current evidence concerning radiosurgical treatment (SRS) of newly diagnosed brain metastasis and to compare SRS as a single or additional treatment to treatment alternatives with regard to medical effectiveness and safety. METHODS A structured search of electronic databases was performed to identify relevant publications from 2002 through 2007. Studies targeting patients with brain metastases were included. Standardised quality assessment and data extraction were performed. RESULTS Of 1496 publications, 16 studies were included. The mean survival in most studies was less than 12 months. There was evidence that SRS plus WBRT was associated with improved local tumour control and neurological functioning compared to either treatment alone. Only in patients with single metastasis, this resulted in improved survival. There was inconclusive evidence when comparing SRS to WBRT, Neurosurgery (NS) or Hypofractionated Radiotherapy (HCSRT). The Quality of life (Qol) was not investigated. CONCLUSION SRS plus WBRT was associated with improved local tumour control and neurological functioning compared to either treatment alone. Only in certain patients, this resulted in improved survival. Methodologically rigorous studies are therefore warranted to investigate further treatment options, and in view of the poor prognosis, to investigate Qol and neurological functioning.

[1]  G. Barnett,et al.  Posterior Fossa Metastases: Aggressive Treatment Improves Survival , 2004, Stereotactic and Functional Neurosurgery.

[2]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[3]  D. Rades,et al.  Whole‐brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases , 2007, Cancer.

[4]  J. Debus,et al.  Treatment of Cerebral Metastases from Breast Cancer with Stereotactic Radiosurgery , 2004, Strahlentherapie und Onkologie.

[5]  M. Mehta,et al.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. , 2002, International journal of radiation oncology, biology, physics.

[6]  H. Shirato,et al.  Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. , 2007, International journal of radiation oncology, biology, physics.

[7]  J. O'fallon,et al.  A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. , 2003, International journal of radiation oncology, biology, physics.

[8]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[9]  David E Morris,et al.  The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. , 2005, International journal of radiation oncology, biology, physics.

[10]  Hiroki Shirato,et al.  Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .

[11]  Roy A Patchell,et al.  The management of brain metastases. , 2003, Cancer treatment reviews.

[12]  G. Jhangri,et al.  Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and meta-analysis. , 2006, Cancer treatment reviews.

[13]  W. Regine,et al.  Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[14]  A. Bergenheim,et al.  Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. , 2005, International journal of radiation oncology, biology, physics.

[15]  R. Harbour,et al.  A new system for grading recommendations in evidence based guidelines , 2001, BMJ : British Medical Journal.

[16]  D. Schmid,et al.  Chirurgie der Hirnmetastasen , 2002 .

[17]  B. Young,et al.  Demographics of brain metastasis. , 1996, Neurosurgery clinics of North America.

[18]  R. Müller,et al.  Linac Radiosurgery Versus Whole Brain Radiotherapy for Brain Metastases , 2004, Strahlentherapie und Onkologie.

[19]  J. Posner,et al.  Management of brain metastases. , 1992, Revue neurologique.

[20]  D. Rades,et al.  Stereotactic radiosurgery alone versus resection plus whole‐brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients , 2007, Cancer.

[21]  W R Markesbery,et al.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.

[22]  E. Rakovitch,et al.  Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. , 2005, Cancer treatment reviews.

[23]  L. Deangelis,et al.  Radiation‐induced dementia in patients cured of brain metastases , 1989, Neurology.

[24]  R. Shi,et al.  Survival in Relation to Radiotherapeutic Modality for Brain Metastasis: Whole Brain Irradiation vs. Gamma Knife Radiosurgery , 2004, American journal of clinical oncology.

[25]  P. Cornu,et al.  Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. , 2003, Lung cancer.

[26]  G. Barnett,et al.  Posterior Fossa Metastases: Risk of Leptomeningeal Disease When Treated with Stereotactic Radiosurgery Compared to Surgery , 2004, Journal of Neuro-Oncology.